Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The chronic and relapsing nature of vulvar lichen sclerosus (VLS) represents a challenge for its long-term management after an effective treatment with topical corticosteroids. OBJECTIVES: To assess the effectiveness of proactive, twice-weekly application of mometasone furoate 0·1% ointment, compared with daily topical vitamin E or cold cream, in keeping VLS in remission and reducing the risk of relapse after 3 months of treatment with topical corticosteroid. METHODS: In total, 27 patients affected with VLS were enrolled into a 12-week active treatment phase (AP) with topical mometasone furoate 0·1% ointment once daily. Those who achieved disease remission entered a 52-week maintenance phase (MP) in which patients were randomized to apply either mometasone furoate 0·1% ointment twice weekly, a cold cream once daily or topical vitamin E once daily. The primary efficacy parameters were the relapse rate and the mean time to relapse. RESULTS: Twenty-five patients considered to have been completely or almost completely healed after the AP entered the MP. By the end of the 52-week MP, 10 patients (40%) experienced a relapse: five in the vitamin E group (56%) and five in the cold cream group (62%), while no patient in the mometasone furoate 0·1% ointment group had a relapse. The occurrence of VLS relapse for patients in therapy with both vitamin E and cold cream was significantly higher than for those in proactive therapy with topical corticosteroid. The median time to relapse was the same (21·6 weeks) for the vitamin E and the emollient groups. CONCLUSIONS: Once VLS has been stabilized with topical corticosteroids, twice-weekly proactive application of mometasone furoate 0·1% ointment over 56 weeks was found to be an effective and safe therapy option in maintaining VLS remission and in preventing the occurrence of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuriyama, K., Shimizu, T., Horiguchi, T., Watabe, M., & Abe, Y. (2002) · Inflammation Research · doi:10.1007/pl00012416 · Cited by 30
Cited by
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
Kirtschig, G., Becker, K., Günthert, A., Jasaitiene, D., Cooper, S., Chi, C. ‐., Kreuter, A., Rall, K. K., Aberer, W., Riechardt, S., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13136 · Cited by 350
Lichen Sclerosus—Presentation, Diagnosis and Management
Kirtschig, G. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0337 · Cited by 185
2016 European guideline for the management of vulval conditions
van der Meijden, W. I., Boffa, M. J., ter Harmsel, W. A., Kirtschig, G., Lewis, F. M., Moyal‐Barracco, M., Tiplica, G. S., & Sherrard, J. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14096 · Cited by 117
Topical proactive therapy in dermatology. A scoping review
Makowska, K., Nowaczyk, J., Samochocki, Z., Blicharz, L., & Rudnicka, L. (2023) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.129454 · Cited by 10
“[55] in 2013, patients who had responded to 12-week reactive treatment were enrolled in a 52-week maintenance therapy of vulvar lichen sclerosus (< 3 in every category or a total ≤ 4 points assessed in the Global Objective Scale, GOS).”
Method
Metadata
- Authors
- Virgili, A., Minghetti, S., Borghi, A., & Corazza, M.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06
- Volume
- 168
- Issue
- 6
- Pages
- 1316-1324
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W2065017552
- Cited by
- 66
- References
- 1
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. https://app.cochat.ai/papers/10.1111/bjd.12273
- The paper
- Virgili, A., Minghetti, S., Borghi, A., & Corazza, M. (2013). Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. British Journal of Dermatology. https://doi.org/10.1111/bjd.12273
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.